
16/07/2025
While on somatostatin analog (SSA) therapy, Randy continued to experience carcinoid syndrome diarrhea (CSD) symptoms. His doctor recommended adding XERMELO to his treatment plan. Hear about Randy’s experience with XERMELO + SSAs: bit.ly/XERMELO-Patient-Spotlight
Indication
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.
Important Safety Information
• Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
• XERMELO may cause constipation which can be serious. You should stop taking
XERMELO if severe constipation or severe, persistent, or worsening abdominal pain
develops. Talk to your doctor if you have these symptoms.
• The most common side effects of XERMELO include nausea, headache, increase in
liver enzymes, depression, flatulence, decreased appetite, swelling of your hands and
feet, fever, abdominal pain, and constipation.
• Talk to your doctor about all medications you are taking as some may interact
with XERMELO.
• XERMELO is not recommended if you have moderate or severe liver impairment.
You are encouraged to report negative side effects of prescription drugs to the FDA. To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also contact TerSera Therapeutics at 1-844-334-4035 or medicalinformation@tersera.com.
Please see Full Prescribing Information: bit.ly/XERMELO_PI